Table 1.
Type of disease | Sample | Species | Biomarker | Ref. | |
Intrahepatic | Drug-induced liver injury (DILI) | Plasma/serum/cell culture | Mouse/rat/human | miR-122 [↑] | [25,26] |
Non-alcoholic fatty liver disease (NAFLD)/non-alcoholic steatohepatitis (NASH) | Cell culture | Mouse | miR-128-3p [↑]; VNN1 | [27] | |
Alcoholic liver disease (ALD) | Serum/cell culture | Mouse/human | miR-192, miR-30a [↑]; CD40L, Hsp90 | [28,29] | |
Hepatocellular carcinoma (HCC) | Cell culture | Human | Vascular endotelial growth factor 1, MMP2, MMP9; miR-584, miR-517c, miR-378, miR-520f, miR142-5p, miR-451, miR-518d, miR-215, miR376a, miR-133b, and miR-367 | [31-33] | |
Viral hepatitis (HBV/HCV) | Cell culture | Human | Viral RNA; CCL5 | [34] | |
Extrahepatic | Pulmonary disease | Serum/cell culture | Rat | Arg 1 | [37] |
Alzheimer’s disease (AD) | CSF/blood/tissue | Human | β-amiloyd; miR-193b, miR-132 [↓] | [39,41] | |
Parkinson’s disease (PD) | Cell culture | Mouse | α-sinucleyn | [42] | |
Multiple Sclerosis (MS) | Serum/cell culture | Mouse/human | Beta-2-microglobulin, MHC-II, CD40,ICOSL; miR-122-5p, miR-196b-5p, miR-301a-3p, miR-5p [↓] | [43,44] | |
Cardiovascular disease (CVDs) | Cell culture/pericardial fluid | Rat/mouse | Hsp90, IL-6; miR-21-3p [↑] | [46,47] | |
Immunopathology | Cell culture | Human | mtDNA | [48] |
VNN1: Vanin-1; MMP: Matrix metalloproteinase.